Antibodies‐to‐infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn’s disease

2021 ◽  
Author(s):  
Ruben J. Colman ◽  
Ye Xiong ◽  
Tomoyuki Mizuno ◽  
Jeffrey S. Hyams ◽  
Joshua D. Noe ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Clinical Response ◽  
Dose Intensification ◽  
Paediatric Crohn’S Disease

scholarly journals Ustekinumab Dose Intensification in Paediatric Crohn's Disease

2021 ◽  
Author(s):  
Rosa Rodríguez‐Mauriz ◽  
Carlos Seguí Solanes ◽  
Isabel Masiques Mas ◽  
Nuria Rudi Sola
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Dose Intensification ◽  
Paediatric Crohn’S Disease

Sa1994 Efficacy of Infliximab for Japanese Paediatric Crohn's Disease Patients

2012 ◽  
Vol 142 (5) ◽  
pp. S-376 ◽  
Author(s):  
Yoko Yokoyama ◽  
Ken Fukunaga ◽  
Hiroto Miwa ◽  
Takayuki Matsumoto
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Paediatric Crohn’S Disease

A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease

2018 ◽  
Vol 88 (2) ◽  
pp. 89-99 ◽  
Author(s):  
Víctor Manuel Navas-López ◽  
Gemma Pujol-Muncunill ◽  
Enrique Llerena ◽  
María Navalón Rubio ◽  
David Gil-Ortega ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Real World ◽  
First Line ◽  
Paediatric Crohn’S Disease

scholarly journals P537 Early predictors of long term clinical response to adalimumab in Crohn's disease

2013 ◽  
Vol 7 ◽  
pp. S225-S226
Author(s):  
M. Martinato ◽  
T. Slongo ◽  
M. Piovanello ◽  
M. Rigato ◽  
A. Ugoni ◽  
...  
Keyword(s):  
Crohn’S Disease ◽  
Crohn's Disease ◽  
Clinical Response ◽  
Early Predictors
Sign in / Sign up

Export Citation Format

Share Document